A novel power prior approach for borrowing historical control data in clinical trials

被引:5
作者
Shi, Yaru [1 ]
Li, Wen [2 ]
Liu, Guanghan [1 ]
机构
[1] Merck & Co Inc, Late Dev Stat, Biostat & Res Decis Sci, North Wales, PA 19454 USA
[2] Pfizer Inc, Vaccine Clin Res & Dev, Collegeville, PA USA
关键词
Bayesian statistics; power prior; historical data; clinical trials;
D O I
10.1177/09622802221146309
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
There has been an increased interest in borrowing information from historical control data to improve the statistical power for hypothesis testing, therefore reducing the required sample sizes in clinical trials. To account for the heterogeneity between the historical and current trials, power priors are often considered to discount the information borrowed from the historical data. However, it can be challenging to choose a fixed power prior parameter in the application. The modified power prior approach, which defines a random power parameter with initial prior to control the amount of historical information borrowed, may not directly account for heterogeneity between the trials. In this paper, we propose a novel approach to pick a power prior based on some direct measures of distributional differences between historical control data and current control data under normal assumptions. Simulations are conducted to investigate the performance of the proposed approach compared with current approaches (e.g. commensurate prior, meta-analytic-predictive, and modified power prior). The results show that the proposed power prior improves the study power while controlling the type I error within a tolerable limit when the distribution of the historical control data is similar to that of the current control data. The method is developed for both superiority and non-inferiority trials and is illustrated with an example from vaccine clinical trials.
引用
收藏
页码:493 / 508
页数:16
相关论文
共 19 条
  • [1] Center for Disease Control and Prevention, FAST FACTS YOU NEED
  • [2] Use of a historical control group in a noninferiority trial assessing a new antibacterial treatment: A case study and discussion of practical implementation aspects
    Dejardin, David
    Delmar, Paul
    Warne, Charles
    Patel, Katie
    van Rosmalen, Joost
    Lesaffre, Emmanuel
    [J]. PHARMACEUTICAL STATISTICS, 2018, 17 (02) : 169 - 181
  • [3] Evaluating water quality using power priors to incorporate historical information
    Duan, YY
    Ye, KY
    Smith, EP
    [J]. ENVIRONMETRICS, 2006, 17 (01) : 95 - 106
  • [4] Food and Drug Administration, 2020, INT FDA COMPL INN TR
  • [5] Food and Drug Administration, 2018, GUID IND E10 CHOIC C
  • [6] Marginal likelihood estimation via power posteriors
    Friel, N.
    Pettitt, A. N.
    [J]. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 2008, 70 : 589 - 607
  • [7] Gelman A., 2004, Bayesian Data Analysis, V2nd
  • [8] Hierarchical Commensurate and Power Prior Models for Adaptive Incorporation of Historical Information in Clinical Trials
    Hobbs, Brian P.
    Carlin, Bradley P.
    Mandrekar, Sumithra J.
    Sargent, Daniel J.
    [J]. BIOMETRICS, 2011, 67 (03) : 1047 - 1056
  • [9] Bayesian semiparametric meta-analytic-predictive prior for historical control borrowing in clinical trials
    Hupf, Bradley
    Bunn, Veronica
    Lin, Jianchang
    Dong, Cheng
    [J]. STATISTICS IN MEDICINE, 2021, 40 (14) : 3385 - 3399
  • [10] Ibrahim JG, 2000, STAT SCI, V15, P46